Recent Headlines
AnaSpec Highlights Speedy 28-Day Custom Polyclonal Antibody
When traditional protocols can take 70+ days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec, EGT Group asked, "Is there a way to develop custom antibodies faster without sacrificing quality in the finished product?" Here's the answer. The Speedy... - August 24, 2012 - AnaSpec, EGT Group
AnaSpec Offers Phosphospecific Antibodies Production
Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that results in the modification of the activity of the phosphorylated molecule by inducing small conformational changes within the molecule.1-2 Catalyzed by protein kinases, phosphate groups can be added via the... - August 17, 2012 - AnaSpec, EGT Group
Pediatric Brain Tumor Foundation Names Robin Boettcher CEO
The Board of Directors of the Pediatric Brain Tumor Foundation (PBTF) has named Robin Boettcher as chief executive officer. She succeeds PBTF co-founder Dianne Traynor, who died last month. Boettcher, who begins her new role on Sept. 10, brings extensive nonprofit experience, including leadership positions with the National Parkinson Foundation and the Leukemia & Lymphoma Society. - August 16, 2012 - Pediatric Brain Tumor Foundation
VIRUN® Closes $2.1 Million Series-A Funding to Bolster Innovation and World-Wide Expansion
After almost 10 years of self-funding growth and business expansion, VIRUN is ready to further-illuminate its presence and capitalize on its patented technology portfolio and product development. - August 02, 2012 - VIRUN
AnaSpec Highlights Beta-Amyloid (1-40) Peptides
ß-Amyloid (1-40) together with ß-Amyloid (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs, with Ab (1-42) being more neurotoxic. These undergo post-secretory aggregation and deposition in the Alzheimer’s diseased... - August 01, 2012 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, Closes Distribution Agreement for Stem Cells, Primary Cells and Reagents with Cyagen Biosciences Inc., China, for the German Market
A leading stem cell producer, Cyagen offers one of the most comprehensive lists of research-use stem cells. Other products include cell culture and differentiation media, cell culture supplements, and an assortment of related research reagents. - July 29, 2012 - MoBiTec GmbH
AnaSpec Highlights Beta-Amyloid (1-42) Peptides
Harnessing over a decade's worth of experience and a multi-level technology platform that includes peptides, antibodies, dyes and assay kits, AnaSpec, EGT Group is one of the world's most trusted sources of integrated proteomic solutions specifically designed for Alzheimer's Disease... - July 25, 2012 - AnaSpec, EGT Group
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
MoBiTec GmbH Introduces New High Performance Expression Vectors for Bacillus Subtilis
MoBiTec GmbH, Germany, further expands its unique portfolio of non-E. coli expression vectors. The new Pgrac100 vectors for gene expression in Bacillus subtilis complement the current product line by more efficient tools. Available are vectors with His-tag and Strep-tag for easy purification of proteins generated in the cytoplasm. - July 20, 2012 - MoBiTec GmbH
SFL’s Managing Director Receives Open University Business School’s Alumni Award for Outstanding Contribution to an Organisation 2012
The Open University Business School Alumni Network nominates and elects individuals that demonstrate best the application of learnings from the Open University MBA training and achievement of outstanding results. - July 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.
TransEnterix Takes Minimally Invasive SPIDER Surgical System to India
Laparoscopic surgeon Dr. Michel Gagner headlines symposium in New Delhi's Max Institute. - July 12, 2012 - TransEnterix
MoBiTec GmbH Introduces First Secretion Vectors for the Lactococcus lactis Gene Expression System NICE®, Developed by NIZO Food Research
NIZO food research has developed the first commercially available secretion vectors for the widely used Nisin Controlled gene Expression system NICE®. The NICE® System is a Gram-positive gene expression system for Lactococcus lactis already used by many labs all around the world. The NICE System as well as the secretion vectors are marketed worldwide by Germany-based MoBiTec GmbH. With these new secretion vectors MoBiTec expands its rich portfolio of non-E. coli vectors and expression systems. - July 04, 2012 - MoBiTec GmbH
AnaSpec Introduces SensoLyte® Beta-Amyloid ELISA Kits
AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat β-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid... - June 29, 2012 - AnaSpec, EGT Group
AnaSpec Offers PTM Peptide Synthesis
Proteins undergo post-translational modifications (PTM) as a mechanism to expand the coding capacity of genes.1 PTMs found in histone “tails” (amino termini) such as acetylation, methylation and phosphorylation affect chromatin structure and exquisitely regulate gene... - June 27, 2012 - AnaSpec, EGT Group
SFL’s Managing Director Invited to Chair Session and Speak at DIA 48th Annual Meeting in Philadelphia
SFL's Managing Director updates DIA attendees on Revision of European Medical Device Directives. - June 27, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
AnaSpec Offers Industry’s Longest Wavelength Assay Kit for HDAC Dectection
Current HDAC assay kits have been based on a short wavelength substrate whose detection is darkened by the presence of autofluorescence interference. SensoLyte® has ushered in the dawn of ultra-sensitivity. AnaSpec, EGT Group’s SensoLyte® 520 HDAC Activity Assay Kit is the... - June 20, 2012 - AnaSpec, EGT Group
MiTeGen Spring 2012 Catalog Available Online or in Hardcopy
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has released a catalog of their current products for crystallographers. - June 15, 2012 - MiTeGen, LLC
MiTeGen Awarded $185K NIH Phase I STTR Grant to Develop Hyperquenching Devices
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a Phase I STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of a rapid crystal cooling device (“hyperquencher”) for cryocrystallography. - June 15, 2012 - MiTeGen, LLC
Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification
Inventys Research Company has achieved ISO 9001:2008, 14001:2004 and 18000:OSHAS Management System accreditation. The ISO 9001:2008 certification of compliance recognizes that the policies, practices, and procedures of Inventys ensure consistent quality in the products and services Inventys... - June 13, 2012 - Inventys Research Company Pvt Ltd.
SFL’s Senior Communication Manager to Speak at the 8th Annual Conference of the Pharmaceutical Contract Management Group
SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled “The Regulatory Framework for New Drug Innovation” at the 8th Annual Conference of the Pharmaceutical Contract Management Group. - June 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
AnaSpec Offers Anti-5-Methylcytidine (Clone 33D3)
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - June 06, 2012 - AnaSpec, EGT Group
OmegaH2O® Clear Shelf Stable Omega-3, CoQ10 and Other Non Polar Compounds Patent Application 12/383,244 Approved in Europe and Notice of Allowance in U.S.
VIRUN, Inc. Food and Beverage Technology Division announces today that without continuance and as a result of innovation and novelty; patent application 12/383,244 has been approved in Europe and Notice of Allowance in the U.S. 12/383,244 allows the only patented non polar compounds, such as Omega-3, dissolve into foods, beverages and supplements clearer and shelf stable. - June 04, 2012 - VIRUN
AnaSpec Offers a Wide Selection of GO® Histone Peptides
AnaSpec, EGT Group offers a wide selection of GO® (catalog) Histone peptides that are biotin-labeled. Single or combinations of post-translational modified (PTM) amino acid-containing biotinylated histone peptide sequences have been used in applications such as pull-down assays.1-2 Generally... - May 31, 2012 - AnaSpec, EGT Group
Royal Care Pharmacy (RCP) Joins PCCA
RCP is pleased to announce PCCA membership. - May 31, 2012 - Royal Care Pharmacy Inc
TransEnterix's Single-Incision SPIDER® Surgical System Used for First Time in UK
International renowned surgeon Dr. Michel Ganger performed gastric sleeve through patient's belly button. - May 31, 2012 - TransEnterix
AnaSpec Showcases Fluorescent Nucleic Acid Probes
The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. Accurate detection of DNA/RNA is key to the success of these techniques. DNA/RNA concentration is often measured by UV absorbance at... - May 19, 2012 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Peptides Synthesis
PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group
Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry
Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc
Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium
Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc
Mitegen Announces Consolidation and Improvements to MicroLoops™ Product Lines
MicroLoops™ and MicroLoops™ HT product lines merged and improved with Dual thickness technology, providing an economical option in premium crystal mounts. - May 09, 2012 - MiTeGen, LLC
AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific
AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York
They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.
AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa
AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics
AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group
Carotech to Showcase Natural Palm Mixed Carotene (Caromin) & Palm Tocotrienol Complex (Tocomin) at FIC 2012, Shanghai
Carotech will share latest scientific developments and application strategies of its Tocomin and Caromin series of ingredients - March 24, 2012 - Carotech Inc.
AnaSpec Develops AMC Resins for SPPS
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, Closes Distribution Agreement for Transcreener® HTS System Platform with BellBrooks Labs, USA
BellBrook Labs, USA, is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. Their proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. The partnership with MoBiTec, Germany, will enable BBL to offer their excellent products for High-Throughput Screening to scientists in Germany. - March 14, 2012 - MoBiTec GmbH
RRI Group/Akesis Has Been Part of 60 Dermatology Development Programs
Let RRI Group/Akesis put its Clinical Experience to work for you. RRI Group/Akesis' passion is helping Companies...Grow. - March 08, 2012 - RRI Group/Akesis
TransEnterix to Unveil New SPIDER Surgical System Instruments at SAGES
Platform delivers smallest incision in single-site market while replicating triangulation of multi-port systems - March 02, 2012 - TransEnterix
MoBiTec GmbH, Germany, to Exhibit at Annual Conference of the Association for General and Applied Microbiology (VAAM) 2012 in Tuebingen, Germany
Presentation of new High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy, Systems for Safe Collection and Transportation of Parasite Material, and a Comprehensive Compilation Booklet on Cell Viability and Cytotoxicity Assays at German Conference of the Association for General and Applied Microbiology (VAAM) 2012. - March 02, 2012 - MoBiTec GmbH
MoBiTec GmbH, Germany, Offers a New Photoconvertible and Photoactivatible Fluorescent Protein Suitable for High-Resolution Microscopy: mIrisFP
MoBiTec GmbH, Germany, supplier of fluorescent probes, screening kits and imaging ware for cutting-edge fluorescence applications and microscopy, introduces mIrisFP, a photoconvertible and photoactivatible fluorescent protein suitable for High-Resolution microscopy: mIrisFP - February 29, 2012 - MoBiTec GmbH
Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC
MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy
MoBiTec GmbH, Germany, supplier of fluorescent probes and research chemicals, introduces a collection of high end imaging tools for cell based imaging, assays and arrays. The product line includes Imaging Dishes and adequate Stage Frames, Imaging Plates, Imaging Chambers, Slide Tray Plates and Affinity Adhesion Slides. For the design of the products excellent materials, high quality processing and assembly technologies and innovative construction principles were chosen. - February 24, 2012 - MoBiTec GmbH
Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC
AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection
AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC